Yield10 Bioscience Inc
Yield10 Bioscience, Inc. operates as an agricultural bioscience company that focuses on commercializing products using the Camelina oilseeds in the United States. Its products include Camelina oil for production of high levels of the omega-3 fatty acids eicosapentanoic acid (EPA) and docosahexanoic acid (DHA); and for use as a low-carbon intensity feedstock oil for biofuels, including biodiesel, … Read more
Yield10 Bioscience Inc (YTEN) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2024: 0.092x
Based on the latest financial reports, Yield10 Bioscience Inc (YTEN) has a cash flow conversion efficiency ratio of 0.092x as of June 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-574.00K) by net assets ($-6.24 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Yield10 Bioscience Inc - Cash Flow Conversion Efficiency Trend (2004–2023)
This chart illustrates how Yield10 Bioscience Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Yield10 Bioscience Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Yield10 Bioscience Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Skillcast Group PLC
LSE:SKL
|
0.387x |
|
Golden Textiles & Clothes Wool
EGX:GTWL
|
N/A |
|
TF703
SA:TF703
|
N/A |
|
EAPBF
OTCGREY:EAPBF
|
N/A |
|
Fingerprint Cards AB (publ)
OTCGREY:FGRRF
|
-0.110x |
|
United Royale Holdings Corp
OTCQB:URYL
|
1.909x |
|
Alternative Investment Trust
AU:AIQ
|
0.026x |
|
Taiwan Bio Therapeutics Co., Ltd
TWO:6892
|
-0.054x |
Annual Cash Flow Conversion Efficiency for Yield10 Bioscience Inc (2004–2023)
The table below shows the annual cash flow conversion efficiency of Yield10 Bioscience Inc from 2004 to 2023.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-2.48 Million | $-10.07 Million | 4.055x | +256.45% |
| 2022-12-31 | $4.40 Million | $-11.40 Million | -2.592x | -348.90% |
| 2021-12-31 | $16.03 Million | $-9.25 Million | -0.577x | +36.44% |
| 2020-12-31 | $9.53 Million | $-8.66 Million | -0.908x | -142.88% |
| 2019-12-31 | $-4.08 Million | $-8.65 Million | 2.118x | +237.89% |
| 2018-12-31 | $5.70 Million | $-8.75 Million | -1.536x | -152.91% |
| 2017-12-31 | $13.50 Million | $-8.20 Million | -0.607x | +73.68% |
| 2016-12-31 | $6.37 Million | $-14.70 Million | -2.308x | -37.54% |
| 2015-12-31 | $13.03 Million | $-21.86 Million | -1.678x | -30.10% |
| 2014-12-31 | $18.80 Million | $-24.24 Million | -1.290x | +1.27% |
| 2013-12-31 | $20.40 Million | $-26.65 Million | -1.306x | -94.87% |
| 2012-12-31 | $47.34 Million | $-31.74 Million | -0.670x | +16.63% |
| 2011-12-31 | $39.46 Million | $-31.73 Million | -0.804x | +40.50% |
| 2010-12-31 | $23.68 Million | $-32.00 Million | -1.351x | -188.77% |
| 2009-12-31 | $55.04 Million | $-25.76 Million | -0.468x | -50.35% |
| 2008-12-31 | $59.09 Million | $-18.39 Million | -0.311x | -154.72% |
| 2007-12-31 | $89.20 Million | $-10.90 Million | -0.122x | -271.66% |
| 2006-12-31 | $109.59 Million | $-3.60 Million | -0.033x | -134.84% |
| 2005-12-31 | $-46.56 Million | $-4.39 Million | 0.094x | +275.06% |
| 2004-12-31 | $-38.97 Million | $-980.67K | 0.025x | -- |